Electrocardiography

Electrocardiograms (ECG) are a primary cardiac diagnostic test that measures the electrical activity in heart to identify overall cardiac function, arrhythmias and areas of ischemia and infarct. Standard 12-lead ECG breaks the 3D structure of the heart into 12 zones, each showing the electrical activity in that specific area of the heart. This narrows down areas where there are issues with coronary artery disease or electrophysiology issues. Many ambulatory heart monitors and consumer-grade ECG monitors use fewer leads so are less specific as to cardiac conditions or location of abnormal heart rhythms, but can show an issue that requires further diagnostic testing or treatment.

FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring
According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials.
FDA clears AI-powered ‘thermometer of the future’ with ECG sensors
BeamO combines electrocardiogram sensors, a stethoscope and a thermometer into a single device that patients can use at home to learn more about their health. Findings can then be submitted for a cardiologist to review.
AI dramatically improves the detection of severe heart attacks
Researchers put an advanced AI model to the test, using it to evaluate the ECG results of more than 1,000 patients. It performed quite well.
P‐waves can help identify Black patients prone to developing AFib
Research that followed patients for more than 13 years suggests increases in ECG PR interval, P‐wave duration and PTFV1 are associated with increased AFib risk in this cohort.
FDA approves Zoll's newest defibrillator-monitor
The device, based on years of user feedback, is now cleared for use in both EMS and hospital settings.

FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring

According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials.

FDA clears AI-powered ‘thermometer of the future’ with ECG sensors

BeamO combines electrocardiogram sensors, a stethoscope and a thermometer into a single device that patients can use at home to learn more about their health. Findings can then be submitted for a cardiologist to review.

artificial intelligence AI heart cardiology

AI dramatically improves the detection of severe heart attacks

Researchers put an advanced AI model to the test, using it to evaluate the ECG results of more than 1,000 patients. It performed quite well.

P‐waves can help identify Black patients prone to developing AFib

Research that followed patients for more than 13 years suggests increases in ECG PR interval, P‐wave duration and PTFV1 are associated with increased AFib risk in this cohort.

The U.S. Food and Drug Administration (FDA) granted pre-market approval (PMA) clearance for Zoll Zenix defibrillator-monitor for EMS and hospital use. It incorporates new technology and features based on years of user feedback.

FDA approves Zoll's newest defibrillator-monitor

The device, based on years of user feedback, is now cleared for use in both EMS and hospital settings.

‘Every second counts’: New Viz.ai platform brings the entire heart attack team together

The new platform provides users with real-time access to high-quality electrocardiograms and patient data. The goal is to ensure everyone is on the same page at all times, with no unnecessary delays.

The Vektor Medical vMap system takes standard 12-lead ECGs and converts them into detailed electro anatomical maps for us in catheter ablation procedures.

AI-powered cardiac mapping system gains an important approval

The vMap System from San Diego-based Vektor Medical turns 12-lead ECGs into 3D maps of the heart. It has already been cleared by the FDA.

FDA clears wearable heart device that captures multiple signals at once

The newly approved device captures electrocardiogram, photoplethysmogram and seismocardiogram signals at the same time. It can also be paired with advanced AI models to monitor patients for specific conditions.